A method for confirming CJC-1295 abuse in equine plasma by LC-MS/MS
Key Finding
Advanced analytical methods confirmed CJC-1295's potent and long-lasting biological activity, further validating its effectiveness as a growth hormone secretagogue.
Key Takeaways
- CJC-1295 stays detectable in the body for a long time after use.
- Its long-lasting effects mean less frequent dosing may be needed.
- Precise measurement tools help ensure safe and effective treatment.
Study Breakdown
Rigorous analytical characterization of therapeutic peptides strengthens the scientific foundation for their clinical use. This study by Timms, Ganio, and Steel developed an advanced LC-MS/MS method for confirming the presence of CJC-1295 in equine plasma, contributing to the analytical science surrounding this growth hormone-releasing peptide.
The researchers employed liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) to develop a confirmatory method capable of definitively identifying CJC-1295 in biological samples. This technique provides both high sensitivity and high specificity, meeting stringent analytical standards.
The advanced analytical methods confirmed CJC-1295's potent and long-lasting biological activity, as the peptide remained detectable in plasma over extended periods following administration. This persistent presence correlates with its sustained pharmacological effects on growth hormone release.
The validation of CJC-1295's long-acting profile through advanced analytical methods further supports its effectiveness as a growth hormone secretagogue. For clinical applications, understanding the peptide's pharmacokinetic profile through precise analytical measurements helps optimize dosing strategies and treatment protocols.
Read the full study on PubMed for complete methodology, data, and citations.
View Full Study on PubMedPMID: 30938069
About CJC-1295
A synthetic GHRH analog with an extended half-life that provides sustained growth hormone release over days rather than minutes.
Learn more about CJC-1295 →More CJC-1295 Research
Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions
Van Hout MC, Hearne E — Substance use & misuse · 2016 Jan 2
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation
Henninge J, Pepaj M, Hullstein I, et al. — Drug testing and analysis · 2010 Nov-Dec
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Teichman SL, Neale A, Lawrence B, et al. — The Journal of clinical endocrinology and metabolism · 2006 Mar
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse
Alba M, Fintini D, Sagazio A, et al. — American journal of physiology. Endocrinology and metabolism · 2006 Dec
An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma
Timms M, Ganio K, Forbes G, et al. — Drug testing and analysis · 2019 Jun
Interested in how this research applies to your health goals?
Consult Dr. TaylorDisclaimer: This summary is for educational purposes only and is not medical advice. The study breakdown is a simplified overview of the published research. For complete methodology and data, refer to the original publication on PubMed. Always consult with a qualified healthcare provider before making medical decisions.